Problems

To learn more about how Pall’s filtration strategy visit our Multi-Barrier Filtration Tour

Intravenous Filters

Water Filters

Breathing Filters

Our Multi-Barrier Filter Concept is designed to protect the adult ICU patient from multiple hazards, particles, microorganisms, endotoxin and intravenous air. Our ultimate goal is to decrease the length of stay of ICU patients and reduce the workload of ICU staff.

Adult ICU

Our Multi-Barrier Filter Concept is designed to protect the infants in the NICU from multiple hazards, particles, microorganisms, endotoxin and intravenous air. Our ultimate goal is to decrease the length of stay of ICU patients and reduce the workload of ICU staff.

Neonatal ICU

Our Multi-Barrier Filter Concept is designed to protect the ICU patient from multiple hazards, particles, microorganisms, endotoxin and intravenous air. Our ultimate goal is to decrease the length of stay of ICU patients and reduce the workload of ICU staff.

Pharmacy

Our multi-barrier filter concept protects patients and staff in the operating room.

Operating Room

Our Multi-Barrier Filter Concept is designed to protect the patient from multiple hazards, particles, microorganisms, endotoxin and intravenous air. Our ultimate goal is to decrease the length of stay of ICU patients and reduce the workload of ICU staff.

Endoscopy

Our Multi-Barrier Filter Concept is designed to protect the paediatric ICU patient from multiple hazards, such as viruses, particles, microorganisms, endotoxin and intravenous air. Our ultimate goal is to decrease the length of stay of ICU patients and reduce the workload of ICU staff.

Paediatric ICU

The Solution

The Proof

Problem: 1 out of 7 ICU patients

Organ Failure

Problem: Amiodarone associated phlebitis rates: up to 85%

Amidarone

Problem: Each day beyond seven days in the ICU increases the odds of death

Length of Stay

Problem: Up to 50% of Pseudomonas aeruginosa infections can be traced back to the water system

Pseudomonas aeruginosa

Problem: Instructions for Use (IFU) can be complicated and difficult to implement

User friendly usage

Problem: Compatibility with Systemic Treatments

Systemic Treatments

Problem: Chemical Compatibility with Surface Disinfectants

Surface Disinfectants

Problem: 10% - 20% of patients suffer from VAP¹

Ventilator associated pneumonia (VAP) 

Problem: Intubation bypasses upper airways and can lead to lung damage and pneumonia

Inadequate airway humidification

Problem: Nebulized drugs can damage ventilators and contaminate the ICU environment

Drug nebulization 

Problem: Patients release aerosols loaded with viruses and bacteria, which can contaminate the ambient air and cause infection

Viral and bacterial contamination of ambient air